Advanced Systemic Mastocytosis clinical trials at UCLA
1 research study open to eligible people
open to eligible people ages 18 years and up
This is an open-label, two-part Phase 2 study investigating CGT9486 for the treatment of patients with Advanced Systemic Mastocytosis (AdvSM), including patients with Aggressive SM (ASM), SM with Associated Hematologic Neoplasm (SM-AHN), and Mast Cell Leukemia (MCL).
Los Angeles, California and other locations
Our lead scientists for Advanced Systemic Mastocytosis research studies include Gary Schiller.